Virtu Financial LLC Aldeyra Therapeutics, Inc. Transaction History

Virtu Financial LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$7.11 - $11.89 $350,480 - $586,105	49,294 New	49,294 $414,000
Q3 2022 Nov 07, 2022	BUY	$3.8 - $7.74 $70,577 - $143,755	18,573 New	18,573 $99,000
Q1 2022 May 17, 2022	SELL	$3.25 - $5.17 $105,303 - $167,513	-32,401 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$3.5 - $9.63 $113,403 - $312,021	32,401 New	32,401 $130,000
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $101,822 - $145,039	-12,824 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$10.44 - $14.85 $133,882 - $190,436	12,824 New	12,824 $145,000
Q1 2021 May 19, 2021	SELL	$6.53 - $14.42 $87,684 - $193,631	-13,428 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$6.31 - $8.13 $93,993 - $121,104	-14,896 Reduced 52.59%	13,428 $92,000
Q3 2020 Dec 11, 2020	BUY	$4.0 - $7.53 $113,296 - $213,279	28,324 New	28,324 $210,000
Q2 2020 Aug 07, 2020	SELL	$1.97 - $5.05 $31,295 - $80,224	-15,886 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$4.73 - $7.98 $75,140 - $126,770	15,886 New	15,886 $92,000
Q3 2019 Nov 20, 2019	SELL	$4.41 - $6.12 $70,260 - $97,503	-15,932 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.0 - $9.0 $95,592 - $143,388	15,932 New	15,932 $96,000
Q4 2018 Jan 16, 2019	SELL	$7.26 - $13.29 $530,146 - $970,475	-73,023 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.8 - $14.35 $496,556 - $1.05 Million	73,023 New	73,023 $1.01 Million
Q2 2018 Jul 30, 2018	SELL	$6.95 - $9.18 $90,822 - $119,964	-13,068 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$6.95 - $9.18 $90,822 - $119,964	13,068 New	13,068 $104,000

116

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $298M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.